TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Surgical Science Sweden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
884,087
|
882,853
|
802,540 |
| Financial expenses |
11,515
|
656
|
19,484 |
| Earnings before taxes |
158,093
|
268,264
|
208,173 |
| EBITDA |
204,835
|
244,765
|
182,191 |
| Total assets |
5,479,673
|
4,702,673
|
4,649,563 |
| Current assets |
1,426,007
|
991,192
|
826,371 |
| Current liabilities |
512,722
|
234,937
|
305,908 |
| Equity capital |
4,828,639
|
4,345,212
|
4,236,451 |
| - share capital |
2,551
|
2,551
|
2,540 |
| Employees (average) |
256
|
249
|
227 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
88.1%
|
92.4%
|
91.1% |
| Turnover per employee |
3,453
|
3,546
|
3,535 |
| Profit as a percentage of turnover |
17.9%
|
30.4%
|
25.9% |
| Return on assets (ROA) |
3.1%
|
5.7%
|
4.9% |
| Current ratio |
278.1%
|
421.9%
|
270.1% |
| Return on equity (ROE) |
3.3%
|
6.2%
|
4.9% |
| Change turnover |
1,234
|
80,313
|
435,762 |
| Change turnover % |
0%
|
10%
|
119% |
| Chg. No. of employees |
7
|
22
|
106 |
| Chg. No. of employees % |
3%
|
10%
|
88% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.